Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Heron Therapeutics, Inc. (HRTX) had Stock-Based Compensation of $12.96M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$144.28M |
|
$-13.58M |
|
$38.65M |
|
$105.64M |
|
$155.81M |
|
$-11.53M |
|
$-2.05M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-11.53M |
|
$-10.22M |
|
152.45M |
|
152.45M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$209.01M |
|
$14.86M |
|
$24.13M |
|
$233.15M |
|
$91.46M |
|
$174.73M |
|
$175.34M |
|
$266.80M |
|
$-33.65M |
|
$-33.65M |
|
$-33.65M |
|
152.13M |
|
| Cash Flow Statement Financials | |
$-22.53M |
|
$18.71M |
|
$0.94M |
|
$28.68M |
|
$25.80M |
|
$-2.88M |
|
|
Stock-Based Compensation |
$12.96M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.29 |
|
-- |
|
-- |
|
1.24 |
|
-5.19 |
|
73.21% |
|
-7.99% |
|
-7.99% |
|
-7.08% |
|
-9.41% |
|
-9.41% |
|
$-24.21M |
|
-- |
|
-- |
|
-- |
|
0.62 |
|
0.73 |
|
1.83 |
|
199.55 |
|
40.36% |
|
40.36% |
|
-5.82% |
|
-9.63% |
|
$-0.22 |
|
$-0.16 |
|
$-0.15 |
|